Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients
- Conditions
- Protein-Energy MalnutritionHemodialysisKidney Failure, Chronic
- Interventions
- Dietary Supplement: Egg albumin-based protein supplementDietary Supplement: Renal-specific oral supplement
- Registration Number
- NCT01981083
- Lead Sponsor
- Centro Medico Lic Adolfo Lopez Mate
- Brief Summary
Malnutrition is seen frequently in hemodialysis units in most developing countries. Malnutrition increases morbidity and mortality in this population and its treatment improves patient survival and health status The purpose of this study is to compare two strategies to improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml) versus egg albumin-based protein supplement (30 g) on a daily basis.
This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment (SGA) in addition to most used biochemical markers to determine nutritional status.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- Chronic Kidney Disease in Hemodialysis
- Infection
- Liver insufficiency
- Cancer or neoplasia
- Acquired immunodeficiency syndrome
- Intestinal malabsorption syndrome
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Egg albumin-based protein supplement Egg albumin-based protein supplement Powder form, dosage 30 g daily, duration 6 months Renal-specific oral supplement Renal-specific oral supplement Liquid form, dosage 237 ml (one can) daily, duration 6 months
- Primary Outcome Measures
Name Time Method Change in Malnutrition-Inflammation Score Bimonthly, up to six months Change in Subjective Global Assessment Bimonthly, up to six months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centro Medico Lic. Adolfo López Mateos
🇲🇽Toluca, Estado de Mexico, Mexico